Back

Early intensive lipid-lowering therapy prevents development of no-reflow phenomenon and reduces the incidence of post MI LV remodeling

28 August 2017 (14:00 - 18:00)
Organised by:
Congress Presentation Part of: Poster session 5 - STEMI / NSTEMI Infarction acute phase STEMI ESC Premium Access ESC Congress 2017

About the speaker

Photo
Associate Professor Yaroslav Lutay

The M.D.Strazhesko Institute of Cardiology, Kyiv (Ukraine)

69 More presentations in this session

Presentation thumbnail
Associate Professor E. Fabris (Trieste, IT)
Abstract
Presentation thumbnail
Doctor C. Bachetti (Bologna, IT)
Abstract
Presentation thumbnail
Professor W. Doehner (Berlin, DE)
Abstract
Presentation thumbnail
Doctor S. Furudono (Nagasaki, JP)
Abstract Slides
Presentation thumbnail
Doctor M. Kato (Mie, JP)
Abstract Slides

Access the full session

Session thumbnail
Poster session 5 - STEMI / NSTEMI

The Event

Event poster

ESC Congress 2017

28 August 2017 14:00 CET
You may be interested in
thumbnail
Webinar
Reducing risk in the post-MI patient
6 September 2023
thumbnail
Congress Presentation
Early inflammation and left ventricular remodeling after acute ST-elevation myocardial infarction: the Neutrophil-to-Lymphocyte Ratio as a predictor of cardiac dysfunction
21 March 2026
thumbnail
Congress Presentation
Intensification of lipid lowering therapy before and after publication of the IMPROVE-IT trial: A temporal analysis from the SPUM-ACS cohort
1 September 2019
thumbnail
Congress Presentation
Revascularisation for HFrEF
21 May 2023

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources